MENU
+Compare
AXSM
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$105.34
Change
+$1.12 (+1.07%)
Capitalization
5.14B

AXSM Axsome Therapeutics Forecast, Technical & Fundamental Analysis

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AXSM with price predictions
Apr 23, 2025

AXSM in upward trend: price may jump up because it broke its lower Bollinger Band on April 04, 2025

AXSM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where AXSM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AXSM's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on AXSM as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AXSM just turned positive on April 21, 2025. Looking at past instances where AXSM's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXSM advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

AXSM moved below its 50-day moving average on March 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AXSM crossed bearishly below the 50-day moving average on April 02, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXSM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AXSM entered a downward trend on April 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXSM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (90.090) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (13.089) is also within normal values, averaging (252.992).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AXSM is expected to report earnings to fall 15.58% to -129 cents per share on May 05

Axsome Therapeutics AXSM Stock Earnings Reports
Q1'25
Est.
$-1.30
Q4'24
Missed
by $0.58
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.36
Q1'24
Missed
by $0.22
The last earnings report on February 18 showed earnings per share of -153 cents, missing the estimate of -95 cents. With 722.70K shares outstanding, the current market capitalization sits at 5.14B.
A.I. Advisor
published General Information

General Information

a provider of biopharmaceutical services for pain and other nervous system

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
One World Trade Center
Phone
+1 212 332-3241
Employees
545
Web
https://www.axsome.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BITX44.301.83
+4.31%
2x Bitcoin Strategy ETF
JCTR72.561.37
+1.92%
JPMorgan Carbon Transition US Eq ETF
SPXN56.811.07
+1.92%
ProShares S&P 500® ex-Financials
EYLD31.360.37
+1.19%
Cambria Emerging Shareholder Yield ETF
CDX23.070.12
+0.52%
Simplify High Yield ETF

AXSM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AXSM has been loosely correlated with CRNX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if AXSM jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXSM
1D Price
Change %
AXSM100%
+0.39%
CRNX - AXSM
38%
Loosely correlated
+3.55%
ACHV - AXSM
37%
Loosely correlated
-2.02%
SWTX - AXSM
36%
Loosely correlated
+1.75%
XENE - AXSM
36%
Loosely correlated
+2.23%
VANI - AXSM
36%
Loosely correlated
+1.86%
More